Graft SurvivalKidney TransplantationGraft RejectionSurvival RateTissue DonorsLiver TransplantationTransplantation, HomologousCell SurvivalCadaverTreatment OutcomeHeart TransplantationImmunosuppressive AgentsTime FactorsLiving DonorsRetrospective StudiesPancreas TransplantationCorneal TransplantationSurvival AnalysisTacrolimusImmunosuppressionGraft Occlusion, VascularTissue and Organ ProcurementHistocompatibility TestingKeratoplasty, PenetratingCyclosporineSkin TransplantationPostoperative ComplicationsDelayed Graft FunctionFollow-Up StudiesMycophenolic AcidDisease-Free SurvivalIslets of Langerhans TransplantationCold IschemiaTransplantsTransplantationOrgan PreservationKaplan-Meier EstimateTransplantation ToleranceSurvivalTransplantation ImmunologyBrain DeathTransplantation, HeterotopicLiver FailureReoperationGraft Enhancement, ImmunologicOrgan TransplantationIsoantibodiesAntilymphocyte SerumProportional Hazards ModelsRisk FactorsPrimary Graft DysfunctionMice, Inbred C57BLKidney Failure, ChronicAzathioprineRats, Inbred LewHLA AntigensDonor SelectionDeathMice, Inbred BALB CBlood Vessel ProsthesisLung TransplantationBone Marrow TransplantationHistocompatibilityKidneyTransplantation, IsogeneicRecurrenceOrgan Preservation SolutionsProspective StudiesMultivariate AnalysisTissue and Organ HarvestingCreatinineBiopsyPolytetrafluoroethyleneAnastomosis, SurgicalIsoantigensGraft vs Host DiseasePrognosisCohort StudiesAge FactorsT-LymphocytesIncidenceWaiting ListsAntibodies, MonoclonalCytomegalovirus InfectionsDrug Therapy, CombinationAcute DiseaseComplement C4bCorneal NeovascularizationAllograftsSirolimusFetal Tissue TransplantationRisk AssessmentImmunoconjugatesRaffinoseVascular PatencySpleenActuarial AnalysisTransplantation, HeterologousBlood Group IncompatibilityPrednisone